ELOVL4 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-11920
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Synthetic peptdide derived from the human ELOVL4 protein (Uniprot: Q9GZR5)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Description
Positive Control: Normal human testis. Expressed in the retina and at much lower level in the brain.
Scientific Data Images for ELOVL4 Antibody
Immunohistochemistry: ELOVL4 Antibody [NBP3-11920]
Immunohistochemistry: ELOVL4 Antibody [NBP3-11920] - Immunohistochemical staining of normal human testis tissue using ELOV4 antibody at 15 ug/ml.Applications for ELOVL4 Antibody
Application
Recommended Usage
Immunohistochemistry
10 - 15 ug/ml
Western Blot
1:400
Application Notes
.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
PBS
Preservative
0.08% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20C. Avoid freeze-thaw cycles.
Background: ELOVL4
Alternate Names
ADMD, cancer/testis antigen 118, CT118, EC 2.3.1.n8, elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4, elongation of very long chain fatty acids protein 4, FLJ17667, FLJ92876,3-keto acyl-CoA synthase ELOVL4, Stargardt disease 3 (autosomal dominant), STGD2, STGD3
Gene Symbol
ELOVL4
UniProt
Additional ELOVL4 Products
Product Documents for ELOVL4 Antibody
Product Specific Notices for ELOVL4 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...